PCI Registry Basel

NCT07814157 · tracked via the Priya Life Science Switzerland tracker

Sponsor

University Hospital, Basel, Switzerland

Phase

Observational

Started

2025-10-01

Last updated

2026-09-10

Condition(s) studied

Coronary Artery DiseaseCoronary StenosisCoronary Occlusion

Study summary

This registry aims to learn more about the best ways to treat coronary artery disease. Information from routine medical care will be collected to compare different treatment approaches, including drug-eluting stents, drug-coated balloons (DCB), and bioresorbable scaffolds (BRS), which gradually dissolve over time. The registry will include people with coronary artery disease who receive an intervention (percutaneous coronary intervention), including those undergoing more complex procedures. By studying treatment outcomes over time, the Registry aims to better understand which therapies work best for different groups of patients and to improve future care for people with coronary artery disease.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: Patients treated at the University Hospital Basel * Undergoing complex PCI (e.g. left main, bifurcation, multivessel PCI, rotational atherectomy or other calcium modification, complex anatomy). The definition complex will be a clinical/ procedural/ anatomical definition made by the operator. * Undergoing CTO or CHIP (Complex High-risk Indicated Patient) procedures * Treated with a DCB strategy * Treated with a BRS Exclusion Criteria: * Patients under 18 years of age

Primary outcome measure(s)

Target Vessel Failure (TVF) — Through study completion, an average of 1 year
Composite endpoint defined as the occurrence of cardiovascular death, target vessel myocardial infarction, or unplanned target vessel revascularisation.

Trial sites (1)

Facility	City	Region	Status
University Hospital Basel	Basel	Canton of Basel-City	Recruiting

More University Hospital, Basel, Switzerland trials in Switzerland

REtinal Markers In Neuroinflammatory Diseases ("REMIND") Recruiting

ClassIntra® for Better Outcomes in Surgery - CIBOSurg Recruiting

Protein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate Antidiuresis Recruiting

Boosting Open-Label Placebo Effects in Acute Induced Pain in Healthy Adults Recruiting

Antidepressant Response of DMT Masked With Propofol Recruiting

Other trials for the same condition

The SELUTION DeNovo Study Active, not recruiting

Prospective Registry of Patients Undergoing Cardiac CT With NAEOTOM Alpha PCD-CT Before TAVI Procedure Recruiting

First in Men Study: BIOMAG-I Active, not recruiting

Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS Active, not recruiting

Randomized Comparison of Skeletonized Versus Pedicled Left Internal Thoracic Artery Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07814157 on ClinicalTrials.gov ↗ ← All trials in Switzerland